Filing Flows › Selectis Health (GBCS) › Q1 2025
Selectis Health (GBCS) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 21, 2025
Selectis Health (GBCS) reported revenue of $10.5M for the first quarter 2025 (Q1 2025), +10% from a year earlier and +0.9% from the quarter before. Operating margin was -4.0%, net loss $656K (6.3% of revenue).
Selectis Health, Q1 2025: revenue $10.5M (+10% year over year), operating margin -4.0%, net loss $656K, operating cash flow $1.0M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.5M | +0.9% | +10% |
| Operating profit | −$422K | — | — |
| Net earnings | −$656K | — | — |
| Operating cash flow | $1.0M | — | +315% |
| Free cash flow | $816K | — | +514% |
What changed
Revenue was $10.5M in Q1 2025, up 10% year over year and up 1% from the previous quarter.
Operating costs exceeded revenue by $422K, an operating margin of -4.0%. Total costs grew 7% against revenue growth of 10%. The quarter ended with a net loss of $656K, wider than the previous quarter's $576K loss.
Operating cash flow was $1.0M (up 315% year over year). Non-cash charges added back $363K of depreciation. Working capital and other items added $1.3M. Capital expenditures of $219K left free cash flow of $816K.
Questions
What was Selectis Health's revenue in the first quarter 2025?
Selectis Health (GBCS) reported revenue of $10.5M for the first quarter 2025 (Q1 2025), +10% from a year earlier and +0.9% from the quarter before.
Was Selectis Health profitable in the first quarter 2025?
Operating loss was $422K (-4.0% of revenue) and net loss $656K.
Source: Selectis Health 10-Q on SEC EDGAR.